You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

New view of stomach cancer could hasten better therapies

July 23, 2014

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.

Yawkey Center for Cancer Care 

DF/BWCC named one of '100 Hospitals with Great Oncology Programs'

July 23, 2014

Becker's Hospital Review has named Dana-Farber/Brigham and Women's Cancer Center to its 2014 "100 Hospitals and Health Systems with Great Oncology Programs." Becker's annual list recognizes hospitals that are leaders in cancer research, outcomes, and quality patient care.
 

Matthew Meyerson, MD, PhD in the lab 

Nineteen Dana-Farber scientists listed among world's most influential

July 01, 2014

In an affirmation of worldwide respect for the impact of Dana-Farber research, 19 basic scientists and clinical investigators at the Institute have been listed among "the world's most influential scientific minds." The ranking was based on how frequently their research discoveries have been cited by peers in the past decade.
 

Dana-Farber Cancer Institute recognized as a Magnet® organization for excellence in nursing and patient care
July 16, 2014

Dana-Farber Cancer Institute is recognized as a Magnet® organization for excellence in nursing and patient care for the third time.

U.S. News and World Report ranks Dana-Farber/Brigham and Women’s Cancer Center the top cancer hospital in New England; fourth in U.S.
July 15, 2014

U.S. News and World Report ranks Dana-Farber/Brigham and Women's Cancer Center the top hospital in New England for the 14th straight year.

Antibody halts cancer-related wasting condition
July 13, 2014

Dana-Farber scientists identify a protein that is a cause of cachexia, a severe wasting of fat and muscle in half of all cancer patients, and show that blocking the protein in mice can prevent or halt the debilitating condition.

Fresh Concerns About a Hysterectomy Procedure Linked to Cancer Spread (New York Times)

July 23, 2014

Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.

Four biological subtypes of stomach cancer defined (ASCO Post)
July 25, 2014

Dr. Adam Bass co-authored a study that developed a molecular classification that divides gastric cancer into four major genomic subtypes

100 Hospitals and Health Systems With Great Oncology Programs (Becker's Hospital Review)
July 22, 2014

Becker's Hospital Review named Dana-Farber/Brigham and Women's Cancer Center to the 2014 edition of "100 Hospitals and Health Systems With Great Oncology Programs."

U.S. News & World Report Announces 2014-15 Best Hospitals Rankings (U.S. News & World Report)
July 15, 2014

The U.S. News and World Report Best Hospitals Guide has ranked Dana-Farber/Brigham and Women's Cancer Center the highest in New England for cancer care for the 14th straight year and fourth overall in the country.

Study Discounts Testosterone Therapy for Early Prostate Cancer (The New York Times)
July 14, 2014

An editorial written by physicians at Dana-Farber supports a study showing there is no compelling evidence to justify using testosterone suppression therapy on men with early-stage prostate cancer.

Ado-Trastuzumab Emtansine Improves Progression-Free Survival vs Physician’s Choice in Advanced HER2-Positive Breast Cancer (ASCO Post)
July 10, 2014

Dr. Ian E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine significantly prolonged progression-free survival in patients with progressive HER2-positive advanced breast cancer.

ASCO Clinical Practice Guideline: Disease Management in Advanced HER2-Positive Breast Cancer With Brain Metastases (ASCO Post)
July 10, 2014

Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Museum of Fine Arts “Artful Healing Program”

July 28, 2014

12:00 PM - 2:00 PM

Blum Resource Center

 Presented by Leonard  P. Zakim Center for Integrative Therapies: 

 

 Join us for an inspiring workshop by experienced art educators from the Museum of Fine Arts, Boston.  The workshop gives participants an opportunity to “explore” the MFA through viewing a slide show of a collection of MFA pieces and then participating in a hands-on activity related to what you have seen. Workshops will take place in the Creative Arts Studio, located inside the Blum Resource Center.  Open to DFCI patients, friends and family members.  All materials provided at no cost.  Please contact the Zakim Center to register 617-632-3322/Zakim_Center@dfci.harvard.edu. 

more

Brain Tumor Support Group

July 28, 2014

1:30 PM - 3:00 PM

Smith Building, Room 335

Support for brain tumor patients and their caregivers. Facilitated by Debra Lafrankie and Nancy Tharler.  Registration is required.  Please call 617-582-7576 for more information and to register. more

Thriving with Yoga - Londonderry

July 28, 2014

5:30 PM - 6:30 PM

40 Buttrick Road, Londonderry

Presented in cooperation with YogaCaps, Inc.  Open to those with a current or past cancer diagnosis.  Beginners or people experienced in yoga are welcome.  Caregivers may also attend.

Call 603-670-0302 to register.

more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    For children:
    888-733-4662


    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now